Oragenics
OGEN
19 hedge funds and large institutions have $106K invested in Oragenics in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
6% more funds holding
Funds holding: 18 → 19 (+1)
0.82% less ownership
Funds ownership: 5.18% → 4.37% (-0.82%)
38% less capital invested
Capital invested by funds: $169K → $106K (-$63.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$51.5K |
| 2 |
Pathstone Holdings
Englewood,
New Jersey
|
+$43.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$16.1K |
| 4 |
HF
HRT Financial
New York
|
+$14.8K |
| 5 |
VF
Virtu Financial
New York
|
+$13.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$88.3K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$48.4K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$26.4K |
| 4 |
Morgan Stanley
New York
|
-$108 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$29 |
OGEN Hedge Fund Activity: Q1 2026 in Review
19 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2026, worth a combined $106K — down 38% from $169K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OGEN positions and 9 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $51.5K. The largest seller was DRW Securities, exiting entirely with an estimated $88.3K sold.
- 19 institutional investors held Oragenics (OGEN) as of Q1 2026, up from 18 in Q4 2025.
- Funds reported $106K of Oragenics stock for Q1 2026, down 38% quarter-over-quarter.
- 11 funds opened new Oragenics positions in Q1 2026 and 9 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q1 2026 was Geode Capital Management, an estimated $51.5K added.
- The largest Oragenics seller in Q1 2026 was DRW Securities, an estimated $88.3K sold.
Based on aggregated 13F filings for Q1 2026.